Clinical Trial Update: ABMSC Infusion Through Hepatic Artery in Portal Hypertension Surgery for the Treatment of Liver Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for ABMSC infusion via hepatic artery in portal hypertension surgery for liver cirrhosis (Phase 2/3); current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Decompensation
• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• ABMSC infusion via hepatic artery

Snippet

Sponsor: Wenzhou Medical University | Conditions: Liver Cirrhosis, Portal Hypertension | Phase 2, Phase 3 | Status: UNKNOWN